NDC 72266-237-01 - DOXYCYCLINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72266-237
- Requested NDC
- 72266-237-01
- Package NDCs from labels
- 72266-237-01, 72266-237-05
- Manufacturer
- FOSUN PHARMA USA INC | Gland Pharma Limited
- Effective date
- 2025-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DOXYCYCLINE - FOSUN PHARMA USA INC | Gland Pharma Limited | FOSUN PHARMA USA INC | Gland Pharma Limited | 2025-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72266-237-01 | DOXYCYCLINE | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 6 | |
| 72266-237-05 | DOXYCYCLINE | 5 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 5 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72266-237-01 | EA - Each | 72266-237 | 4e56dc5a-99eb-4ea7-a739-b9786aac8631 | 1 | 2023-07-06 |
| 72266-237-05 | EA - Each | 72266-237 | 8a20933a-e1b8-489e-beba-2f3c2bfbc122 | 1 | 2023-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucolytic Drainage Liquescence 3017 | MUCOLYTIC DRAINAGE LIQUESCENCE | Professional Complementary Health Formulas | f6dd9b87-053d-4d88-b0e4-7693f5524ce7 | 2026-01-08 | Warnings | PQ6CK8PD0R |
| Anti-Hives Drops 2004 | ANTI-HIVES DROPS | Professional Complementary Health Formulas | 45ae94f2-4310-41d3-8532-ef9b132b3282 | 2026-01-08 | Warnings | PQ6CK8PD0R |
| Pain Formula Drops 2046 | PAIN FORMULA DROPS | Professional Complementary Health Formulas | 4456c022-5aac-49b4-b976-b629525f3d49 | 2026-01-08 | Warnings | PQ6CK8PD0R |
| Ferralet 90 | IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM | Mission Pharmacal Company | 0be2918e-55b3-4c66-aba0-09099a1c7770 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Northwind Health Company, LLC | f7f6dc0d-cf8f-50b5-e053-6294a90a9e59 | 2026-01-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Northwind Health Company, LLC | f309ccbb-b68a-3190-e053-2995a90a0ad4 | 2026-01-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Lunavira | MULTIVITAMIN | Oncora Pharma, LLC | 474780d5-dd88-8f1a-e063-6294a90a03dc | 2025-12-31 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Health Department, Oklahoma State | f39365f9-eb64-00cb-e053-2995a90a8d80 | 2025-12-31 | Warnings | 19XTS3T51U |
| Gestyra | ASCORBIC ACID, CHOLECALCIFEROL, THIAMINE, PYRIDOXAL PHOSPHATE, FOLIC ACID, METHYLCOBALAMIN, CALCIUM CARBONATE, FERROUS GLUCONATE, POTASSIUM IODIDE | Oncora Pharma LLC | f10bf225-c125-4711-893a-78e15be815bb | 2025-12-30 | Warnings | PQ6CK8PD0R |
| TRICON | TRICON | Nnodum Pharmaceuticals | d891ab47-4a05-4b5b-b372-7ddf91699c29 | 2025-12-29 | Adverse reactions | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Macleods Pharmaceuticals Limited | c36798a1-b865-4e94-9905-5af024a9e250 | 2025-12-29 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Major Pharmaceuticals | c4aae81f-0219-450f-aa60-953964f74172 | 2025-12-23 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | QPharma, Inc. | fbd0a22f-b365-c0a2-e053-6394a90a1e07 | 2025-12-19 | Warnings, Adverse reactions | 19XTS3T51U |
| STYE EYE RELIEF SERUM | VITAMIN E | Guangzhou Mizi Biotechnology Co., LTD. | 3f60193e-4b95-6759-e063-6394a90a991c | 2025-12-17 | Warnings | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Golden State Medical Supply, Inc. | 98bf51e7-01f8-e3f7-e053-2995a90a42f0 | 2025-12-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Macleods Pharmaceuticals Limited | 2696f799-7902-4239-807a-9ae85a5d0f1d | 2025-12-16 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | AvPAK | 53ff9f7e-0db0-c841-d334-4cf31f658828 | 2025-12-16 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE DELAYED RELEASE | DOXYCYCLINE HYCLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | f5ee43b2-d6ca-4819-a3d7-07f8421015d7 | 2025-12-16 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Redpharm Drug | 44f2fdde-cf84-6f42-e063-6394a90af94e | 2025-12-11 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.